Annual Cash & Cash Equivalents
$52.37 M
-$30.00 M-36.42%
July 31, 2024
Summary
- As of February 10, 2025, ENZ annual cash & cash equivalents is $52.37 million, with the most recent change of -$30.00 million (-36.42%) on July 31, 2024.
- During the last 3 years, ENZ annual cash & cash equivalents has risen by +$38.85 million (+287.24%).
- ENZ annual cash & cash equivalents is now -50.19% below its all-time high of $105.15 million, reached on July 31, 2007.
Performance
ENZ Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$47.73 M
-$4.64 M-8.85%
October 31, 2024
Summary
- As of February 10, 2025, ENZ quarterly cash and cash equivalents is $47.73 million, with the most recent change of -$4.64 million (-8.85%) on October 31, 2024.
- Over the past year, ENZ quarterly cash and cash equivalents has dropped by -$4.64 million (-8.85%).
- ENZ quarterly cash and cash equivalents is now -60.23% below its all-time high of $120.02 million, reached on April 30, 2007.
Performance
ENZ Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ENZ Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.4% | -8.8% |
| 3 y3 years | +287.2% | +651.0% |
| 5 y5 years | -12.9% | +4.0% |
ENZ Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.4% | +287.2% | -42.0% | +1713.6% |
| 5 y | 5-year | -36.4% | +287.2% | -42.0% | +1713.6% |
| alltime | all time | -50.2% | +8628.5% | -60.2% | >+9999.0% |
Enzo Biochem Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $47.73 M(-8.9%) |
| Jul 2024 | $52.37 M(-36.4%) | $52.37 M(-8.4%) |
| Apr 2024 | - | $57.16 M(-5.1%) |
| Jan 2024 | - | $60.24 M(-13.0%) |
| Oct 2023 | - | $69.21 M(-16.0%) |
| Jul 2023 | $82.37 M(+281.3%) | $82.37 M(+3029.7%) |
| Apr 2023 | - | $2.63 M(-47.9%) |
| Jan 2023 | - | $5.05 M(-58.4%) |
| Oct 2022 | - | $12.13 M(-43.8%) |
| Jul 2022 | $21.60 M(+59.7%) | $21.60 M(-30.6%) |
| Apr 2022 | - | $31.13 M(+648.5%) |
| Jan 2022 | - | $4.16 M(-34.6%) |
| Oct 2021 | - | $6.36 M(-53.0%) |
| Jul 2021 | $13.52 M(-71.7%) | $13.52 M(-10.4%) |
| Apr 2021 | - | $15.09 M(-66.1%) |
| Jan 2021 | - | $44.54 M(-3.0%) |
| Oct 2020 | - | $45.91 M(-4.1%) |
| Jul 2020 | $47.87 M(-20.4%) | $47.87 M(-12.0%) |
| Apr 2020 | - | $54.41 M(+5.6%) |
| Jan 2020 | - | $51.50 M(-9.5%) |
| Oct 2019 | - | $56.89 M(-5.4%) |
| Jul 2019 | $60.15 M(+0.2%) | $60.15 M(-6.1%) |
| Apr 2019 | - | $64.05 M(+52.6%) |
| Jan 2019 | - | $41.98 M(-20.5%) |
| Oct 2018 | - | $52.78 M(-12.1%) |
| Jul 2018 | $60.04 M(-6.4%) | $60.04 M(-4.0%) |
| Apr 2018 | - | $62.56 M(-3.0%) |
| Jan 2018 | - | $64.47 M(-3.6%) |
| Oct 2017 | - | $66.85 M(+4.2%) |
| Jul 2017 | $64.17 M(-5.3%) | $64.17 M(+2.5%) |
| Apr 2017 | - | $62.63 M(+0.3%) |
| Jan 2017 | - | $62.43 M(-7.1%) |
| Oct 2016 | - | $67.21 M(-0.8%) |
| Jul 2016 | $67.78 M(+274.3%) | $67.78 M(+109.4%) |
| Apr 2016 | - | $32.36 M(-12.6%) |
| Jan 2016 | - | $37.02 M(+20.8%) |
| Oct 2015 | - | $30.64 M(+69.2%) |
| Jul 2015 | $18.11 M(+3.7%) | $18.11 M(+26.0%) |
| Apr 2015 | - | $14.38 M(-6.3%) |
| Jan 2015 | - | $15.35 M(-7.5%) |
| Oct 2014 | - | $16.59 M(-4.9%) |
| Jul 2014 | $17.45 M(+93.8%) | $17.45 M(+17.9%) |
| Apr 2014 | - | $14.80 M(+94.3%) |
| Jan 2014 | - | $7.62 M(+2.6%) |
| Oct 2013 | - | $7.43 M(-17.6%) |
| Jul 2013 | $9.01 M(-40.3%) | $9.01 M(+59.6%) |
| Apr 2013 | - | $5.64 M(-43.7%) |
| Jan 2013 | - | $10.02 M(-25.2%) |
| Oct 2012 | - | $13.40 M(-11.1%) |
| Jul 2012 | $15.08 M(+6.5%) | $15.08 M(+187.3%) |
| Apr 2012 | - | $5.25 M(-38.9%) |
| Jan 2012 | - | $8.59 M(-24.5%) |
| Oct 2011 | - | $11.38 M(-19.7%) |
| Jul 2011 | $14.16 M(+61.7%) | $14.16 M(+45.9%) |
| Apr 2011 | - | $9.71 M(+8.0%) |
| Jan 2011 | - | $8.99 M(+2.7%) |
| Oct 2010 | - | $8.75 M(-0.1%) |
| Jul 2010 | $8.76 M(+26.4%) | $8.76 M(+1.9%) |
| Apr 2010 | - | $8.60 M(+5.4%) |
| Jan 2010 | - | $8.16 M(+34.3%) |
| Oct 2009 | - | $6.07 M(-12.3%) |
| Jul 2009 | $6.93 M(-91.2%) | $6.93 M(-8.3%) |
| Apr 2009 | - | $7.55 M(-10.9%) |
| Jan 2009 | - | $8.48 M(-77.0%) |
| Oct 2008 | - | $36.83 M(-53.0%) |
| Jul 2008 | $78.32 M(-25.5%) | $78.32 M(-18.8%) |
| Apr 2008 | - | $96.50 M(-2.1%) |
| Jan 2008 | - | $98.55 M(-5.0%) |
| Oct 2007 | - | $103.79 M(-1.3%) |
| Jul 2007 | $105.15 M(+50.5%) | $105.15 M(-12.4%) |
| Apr 2007 | - | $120.02 M(+8.2%) |
| Jan 2007 | - | $110.92 M(+54.1%) |
| Oct 2006 | - | $71.96 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2006 | $69.85 M(-9.3%) | $69.85 M(-8.0%) |
| Apr 2006 | - | $75.91 M(-0.6%) |
| Jan 2006 | - | $76.36 M(+1.5%) |
| Oct 2005 | - | $75.24 M(-2.3%) |
| Jul 2005 | $76.98 M(+41.3%) | $76.98 M(+4.6%) |
| Apr 2005 | - | $73.59 M(+6.5%) |
| Jan 2005 | - | $69.12 M(+0.7%) |
| Oct 2004 | - | $68.62 M(+25.9%) |
| Jul 2004 | $54.50 M(-13.9%) | $54.50 M(-9.0%) |
| Apr 2004 | - | $59.88 M(+0.1%) |
| Jan 2004 | - | $59.81 M(-5.7%) |
| Oct 2003 | - | $63.45 M(+0.3%) |
| Jul 2003 | $63.27 M(-5.8%) | $63.27 M(-20.0%) |
| Apr 2003 | - | $79.12 M(+4.2%) |
| Jan 2003 | - | $75.94 M(+3.7%) |
| Oct 2002 | - | $73.25 M(+9.1%) |
| Jul 2002 | $67.14 M(+14.4%) | $67.14 M(+5.7%) |
| Apr 2002 | - | $63.54 M(+2.7%) |
| Jan 2002 | - | $61.88 M(+1.1%) |
| Oct 2001 | - | $61.22 M(+4.3%) |
| Jul 2001 | $58.67 M(+15.0%) | $58.67 M(+3.9%) |
| Apr 2001 | - | $56.48 M(+3.9%) |
| Jan 2001 | - | $54.39 M(+1.6%) |
| Oct 2000 | - | $53.54 M(+4.9%) |
| Jul 2000 | $51.03 M(+18.1%) | $51.03 M(+7.1%) |
| Apr 2000 | - | $47.66 M(+2.5%) |
| Jan 2000 | - | $46.50 M(+5.0%) |
| Oct 1999 | - | $44.30 M(+2.5%) |
| Jul 1999 | $43.20 M(+29.0%) | $43.20 M(+3.1%) |
| Apr 1999 | - | $41.90 M(+4.2%) |
| Jan 1999 | - | $40.20 M(+2.6%) |
| Oct 1998 | - | $39.20 M(+17.0%) |
| Jul 1998 | $33.50 M(+32.4%) | $33.50 M(+4.7%) |
| Apr 1998 | - | $32.00 M(+3.2%) |
| Jan 1998 | - | $31.00 M(+3.3%) |
| Oct 1997 | - | $30.00 M(+18.6%) |
| Jul 1997 | $25.30 M(+42.1%) | $25.30 M(+6.8%) |
| Apr 1997 | - | $23.70 M(+2.2%) |
| Jan 1997 | - | $23.20 M(-1.3%) |
| Oct 1996 | - | $23.50 M(+32.0%) |
| Jul 1996 | $17.80 M(+60.4%) | $17.80 M(+11.3%) |
| Apr 1996 | - | $16.00 M(-2.4%) |
| Jan 1996 | - | $16.40 M(+5.8%) |
| Oct 1995 | - | $15.50 M(+39.6%) |
| Jul 1995 | $11.10 M(+164.3%) | $11.10 M(-5.1%) |
| Apr 1995 | - | $11.70 M(-4.9%) |
| Jan 1995 | - | $12.30 M(-21.2%) |
| Oct 1994 | - | $15.60 M(+271.4%) |
| Jul 1994 | $4.20 M(+500.0%) | $4.20 M(-16.0%) |
| Apr 1994 | - | $5.00 M(+4.2%) |
| Jan 1994 | - | $4.80 M(-32.4%) |
| Oct 1993 | - | $7.10 M(+914.3%) |
| Jul 1993 | $700.00 K(-12.5%) | $700.00 K(-36.4%) |
| Apr 1993 | - | $1.10 M(+10.0%) |
| Jan 1993 | - | $1.00 M(+25.0%) |
| Oct 1992 | - | $800.00 K(0.0%) |
| Jul 1992 | $800.00 K(+33.3%) | $800.00 K(+100.0%) |
| Apr 1992 | - | $400.00 K(+33.3%) |
| Jan 1992 | - | $300.00 K(+50.0%) |
| Oct 1991 | - | $200.00 K(-66.7%) |
| Jul 1991 | $600.00 K(-91.7%) | $600.00 K(+100.0%) |
| Apr 1991 | - | $300.00 K(-84.2%) |
| Jan 1991 | - | $1.90 M(-53.7%) |
| Oct 1990 | - | $4.10 M(-43.1%) |
| Jul 1990 | $7.20 M(-75.8%) | $7.20 M(-66.8%) |
| Apr 1990 | - | $21.70 M(-11.8%) |
| Jan 1990 | - | $24.60 M(-10.2%) |
| Oct 1989 | - | $27.40 M(-8.1%) |
| Jul 1989 | $29.80 M(-32.0%) | $29.80 M(-32.0%) |
| Jul 1988 | $43.80 M(-12.9%) | $43.80 M(-12.9%) |
| Jul 1987 | $50.30 M(-5.1%) | $50.30 M(-5.1%) |
| Jul 1986 | $53.00 M(+171.8%) | $53.00 M(+171.8%) |
| Jul 1985 | $19.50 M(-5.8%) | $19.50 M(-5.8%) |
| Jul 1984 | $20.70 M | $20.70 M |
FAQ
- What is Enzo Biochem annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Enzo Biochem?
- What is Enzo Biochem annual cash & cash equivalents year-on-year change?
- What is Enzo Biochem quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Enzo Biochem?
- What is Enzo Biochem quarterly cash and cash equivalents year-on-year change?
What is Enzo Biochem annual cash & cash equivalents?
The current annual cash & cash equivalents of ENZ is $52.37 M
What is the all time high annual cash & cash equivalents for Enzo Biochem?
Enzo Biochem all-time high annual cash & cash equivalents is $105.15 M
What is Enzo Biochem annual cash & cash equivalents year-on-year change?
Over the past year, ENZ annual cash & cash equivalents has changed by -$30.00 M (-36.42%)
What is Enzo Biochem quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ENZ is $47.73 M
What is the all time high quarterly cash and cash equivalents for Enzo Biochem?
Enzo Biochem all-time high quarterly cash and cash equivalents is $120.02 M
What is Enzo Biochem quarterly cash and cash equivalents year-on-year change?
Over the past year, ENZ quarterly cash and cash equivalents has changed by -$4.64 M (-8.85%)